SCHEMBL1068372

SCHEMBL1068372

O=Cc1ncnc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4KA P42356 1/20 0.50
PI4K2B Q8TCG2 1/20 0.50
PI4K2A Q9BTU6 1/20 0.50
PI4KB Q9UBF8 1/20 0.50
PDE4A P27815 1/20 0.50
PDE4B Q07343 1/20 0.50
PDE4C Q08493 1/20 0.50
PDE4D Q08499 1/20 0.50
ADORA2A P29274 2/20 0.47
ERN1 O75460 2/20 0.46
EGFR P00533 3/20 0.43
ABCG2 Q9UNQ0 2/20 0.43
DAPK3 O43293 1/20 0.43
MAP4K4 O95819 1/20 0.43
ABL1 P00519 1/20 0.43
ERBB2 P04626 1/20 0.43
PIM1 P11309 1/20 0.43
PRKACA P17612 1/20 0.43
LTK P29376 1/20 0.43
MAPK8 P45983 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10703592 0.79 SMN1; SMN2 (0.50) PI4KAPI4K2BPI4K2API4KBPDE4A
SCHEMBL160404 0.79 PI4KA (0.50) PI4KAPI4K2BPI4K2API4KBPDE4A
SCHEMBL2008893 0.73 KDM4E (0.52) ERN1RAB9AMAPTMEN1KMT2A
SCHEMBL31132323 0.73 KDM4E (0.52) ERN1RAB9AMAPTMEN1KMT2A
SCHEMBL28587968 0.73 PARP1 (0.49) MAP4K4SMN1; SMN2PARP1MAPTLMNA
SCHEMBL29985318 0.73 PARP1 (0.49) MAP4K4SMN1; SMN2PARP1MAPTLMNA
SCHEMBL28358026 0.73 CSF1R (0.39) EGFRMAP4K4PARP1MEN1KMT2A
SCHEMBL1069237 0.72 ALDH1A1 (0.42) ERN1EGFRSMN1; SMN2PARP1RAB9A
SCHEMBL276986 0.71 PI4KA (0.56) PI4KAPI4K2BPI4K2API4KBPDE4A
4-Aminoquinazoline SCHEMBL30455007 0.71 PI4KA (0.78) PI4KAPI4K2BPI4K2API4KBPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113164458-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-13 CN claimed
CN-113164459-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-03 CN claimed
CN-117946083-A Quinazoline derivative containing piperonal as well as synthesis method and application thereof 贵州大学 2024-04-30 CN claimed
CN-117466942-A Chiral secondary phosphine oxide compound, chiral quinazolinone/pyrimidinone ring derivative based on chiral secondary phosphine oxide compound and application of chiral quinazolinone/pyrimidinone ring derivative 中山大学 2024-01-30 CN claimed
CN-116693554-A Quinazoline-4-ketone compound containing 1,2, 4-triazole [3,4-b ] [1,3,4] thiadiazole, preparation and application 贵州大学 2023-09-05 CN claimed
CN-113200927-B Synthesis method of N- (3-ethynylphenyl) -quinazoline-4-amine 上海橡实化学有限公司 2022-08-26 CN claimed
CN-113200927-A Synthesis method of N- (3-ethynylphenyl) -quinazoline-4-amine 上海橡实化学有限公司 2021-08-03 CN claimed
CN-113164458-A Monoacylglycerol lipase modulators 詹森药业有限公司 2021-07-23 CN claimed
CN-108358896-B Compound for preparing medicine for preventing and treating crop pathogenic bacteria and preparation method 贵州大学 2021-01-08 CN claimed
CN-106995438-B A kind of substituted quinazoline -4- ketone compounds and preparation method thereof and medical usage 中国科学院上海药物研究所 2019-09-20 CN claimed
CN-106995438-A One class substituted quinazoline -4- ketone compounds and preparation method thereof and medical usage 中国科学院上海药物研究所 2017-08-01 CN claimed
CN-104610169-A Quinazoline-containing thioether substituted pentadiene ketone derivatives, and preparation method and application thereof UNIV GUIZHOU 2015-05-13 CN claimed
US-7459415-B1 Lubricant for thin film storage media SEAGATE TECHNOLOGY LLC (US) 2008-12-02 US claimed
CN-1597671-A Quinazoline deriative and preparation method and bioactivity UNIV GUIZHOU (CN) 2005-03-23 CN claimed
US-20030138670-A1 Lubricant for thin film storage media SEAGATE TECHNOLOGY LLC 2003-07-24 US claimed
US-12577243-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2026-03-17 US disclosed
US-20240327410-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2024-10-03 US disclosed
US-20030138670-A1 Lubricant for thin film storage media SEAGATE TECHNOLOGY LLC 2003-07-24 US disclosed
CN-1090621-C Process for preparing quinazolin-4-one derivatives OTSUKA PHARMA CO LTD (JP) 2002-09-11 CN disclosed
CN-1193967-A Process for producing quinazoline-4-one derivatives OTSUKA PHARMA CO LTD (US) 1998-09-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577243-B2 Monoacylglycerol lipase modulators MGLL, LPL, FAAH PI4KA 1537/4885PI4K2B 1874/4885PI4K2A 1993/4885
US-20240327410-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP PI4KA 1736/4885PI4K2B 1856/4885PI4K2A 1876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.